Synthesis of some new C2 substituted dihydropyrimidines and their electrophysiological evaluation as L-/T-type calcium channel blockers

Bioorg Chem. 2019 Jul:88:102915. doi: 10.1016/j.bioorg.2019.04.009. Epub 2019 Apr 11.

Abstract

Drugs targeting different calcium channel subtypes have strong therapeutic potential for future drug development for cardiovascular disorders, neuropsychiatric diseases and cancer. This study aims to design and synthesize a new series of C2 substituted dihydropyrimidines to mimic the structure features of third generation long acting dihydropyridine calcium channel blockers and dihydropyrimidines analogues. The target compounds have been evaluated as blockers for CaV1.2 and CaV3.2 utilizing the whole-cell patch clamp technique. Among the tested compounds, compound 7a showed moderate calcium channel blockade activity against CaV3.2. Moreover, the predicted physicochemical properties and pharmacokinetic profiles of the target compounds recommend that they can be considered as drug-like candidates. The results highlight some significant information for the future design of lead compounds as calcium channel blockers.

Keywords: 1,4-Dihydropyridines; Calcium channels; Dihydropyrimidines; L-type calcium channel blockers Whole patch clamp technique; T-type calcium channel blockers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium Channel Blockers / chemical synthesis
  • Calcium Channel Blockers / pharmacokinetics
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels, L-Type / metabolism*
  • Calcium Channels, T-Type / metabolism*
  • Cell Line
  • Computer Simulation
  • Drug Design
  • Electrophysiology / methods
  • Humans
  • Patch-Clamp Techniques
  • Pyrimidines / chemical synthesis
  • Pyrimidines / pharmacokinetics
  • Pyrimidines / pharmacology*

Substances

  • CACNA1C protein, human
  • CACNA1H protein, human
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Calcium Channels, T-Type
  • Pyrimidines